Real-time enrollment status for this gastroesophageal cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06445972 |
| Recruiting Status | Recruiting |
| Condition | Gastroesophageal Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of March 2, 2026: Clinical trial NCT06445972 is currently recruiting participants. This clinical trial study for gastroesophageal cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06445972 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06445972 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.